Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Portable Neuromodulation Stimulator (PoNS)

N.º K: K253061 · 2026-05-13

SolicitanteHelius Medical, Inc.
Fecha de decisión2026-05-13
Código de productoQCF
Comité asesorNE
DecisiónSubstantially Equivalent

Resumen del dispositivo

Portable Neuromodulation Stimulator (PoNS) is the device name listed in this FDA 510(k) record. The listed applicant is Helius Medical, Inc.. It received FDA 510(k) clearance on 2026-05-13 under 510(k) number K253061. The device is classified under product code QCF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Portable Neuromodulation Stimulator (PoNS)?

Portable Neuromodulation Stimulator (PoNS) is a medical device that received FDA 510(k) clearance on 2026-05-13. The listed applicant is Helius Medical, Inc.. The 510(k) number is K253061.

When did Portable Neuromodulation Stimulator (PoNS) receive FDA 510(k) clearance?

Portable Neuromodulation Stimulator (PoNS) received FDA 510(k) clearance on 2026-05-13, under 510(k) number K253061.

Who is the listed applicant for Portable Neuromodulation Stimulator (PoNS)?

The FDA 510(k) record lists Helius Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Portable Neuromodulation Stimulator (PoNS)?

The FDA product code for Portable Neuromodulation Stimulator (PoNS) is QCF.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑